Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem-cell based therapies for brain tumors.

Stephen Yip1, Khalid Shah

  • 1Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA.

Current Opinion in Molecular Therapeutics
|August 7, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Readiness to Consider and Adopt Genetic and Genomic Tests in Canada-An Update to the State of Readiness Report.

Current oncology (Toronto, Ont.)·2026
Same author

Tumor-to-Tumor Metastasis Involving Vestibular Schwannoma: Case Report and Literature Review.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Progressive Postoperative Cerebral Edema and Ring Enhancement After Hematoma Evacuation.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Histopathological and molecular heterogeneity of dysembryoplastic neuroepithelial tumors.

Journal of neuropathology and experimental neurology·2026
Same author

Comparative Evaluation of Comprehensive DNA and RNA Sequencing Platforms with Subsequent Clinical Validation for Hematolymphoid Malignancies.

Cancers·2026
Same author

Overcoming functional and translational challenges of cellular immunotherapies for solid tumors.

Cancer cell·2026
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Neural stem cells (NSCs) offer promising cell-based therapies for brain tumors due to their self-renewal and migration abilities. Engineered NSCs show potential for eliminating malignant brain cells effectively.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Oncology

Background:

  • Neural stem cells (NSCs) are immature progenitor cells with self-renewal, differentiation, and migration capabilities.
  • NSCs possess inherent tumor-tropic properties, attracting them to pathological areas within the central nervous system.

Purpose of the Study:

  • To review the therapeutic potential of neural stem cells (NSCs) for treating brain malignancies.
  • To highlight the application of engineered NSCs as a cell-based therapy for brain tumors.

Main Methods:

  • Literature review focusing on NSC biology and its application in brain tumor research.
  • Analysis of studies investigating the use of engineered NSCs for therapeutic purposes.

Main Results:

Related Experiment Videos

  • Advances in NSC biology have enabled the development of novel cell-based therapies for brain cancers.
  • Engineered NSCs demonstrate feasibility as therapeutic agents for eliminating malignant brain cells.

Conclusions:

  • Neural stem cells (NSCs) represent a potent tool for treating both diffuse and localized neurological disorders, particularly brain tumors.
  • The inherent properties of NSCs, including tumor-trophism and differentiation capacity, make them highly suitable for targeted cancer therapy.